SLMp53-1 是一种具有良好抗肿瘤活性的野生型和突变型p53再激活剂。 SLMp53-1 介导癌细胞葡萄糖代谢的重编程。 SLMp53-1 减少血管生成，减少内皮细胞管的形成和血管内皮生长因子 (VEGF) 的表达水平。

SLMP53-1 is a wild-type and mutant p53 reactivator with promising antitumor activity. SLMP53-1 mediates the reprograming of glucose metabolism in cancer cells. SLMP53-1 depletes angiogenesis, decreasing endothelial cell tube formation and vascular endothelial growth factor (VEGF) expression levels [1] [2].

1643469-17-3

C20H18N2O2

318.37

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years